HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

human MIRN940 microRNA

Also Known As:

MIRN940 microRNA, human; hsa-mir-940; miR-940, human; microRNA-940, human

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleic Acids: 11752
  - RNA: 69704
    - Untranslated RNA: 2850
      - Small Untranslated RNA: 566
        MicroRNAs: 67298
        human MIRN940 microRNA: 9
    - Antisense RNA: 1599
      - MicroRNAs: 67298
        human MIRN940 microRNA: 9
- Antisense Elements (Genetics): 31
  - Antisense RNA: 1599
    - MicroRNAs: 67298
      - human MIRN940 microRNA: 9

Experts

1.	Benedetto, Chiara: 1 article (06/2022)
2.	Biglia, Nicoletta: 1 article (06/2022)
3.	Fu, Yuanyuan: 1 article (06/2022)
4.	Katsaros, Dionyssios: 1 article (06/2022)
5.	Loo, Lenora: 1 article (06/2022)
6.	Wang, Junlong: 1 article (06/2022)
7.	Wang, Zhanwei: 1 article (06/2022)
8.	Yu, Herbert: 1 article (06/2022)
9.	He, Tongchuan: 1 article (01/2021)
10.	Hu, Binwu: 1 article (01/2021)

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 04/10/2017 - "Results from the Survival analysis showed that hsa-mir-1180 (HR=1.623, 95% CI: 1.114-2.365, P=0.012), hsa-mir-149 (HR=2.400, 95% CI: 1.639-3.514) and hsa-mir-940 (HR=1.704, 95%CI: 1.188-2.443, P=0.004) were independent risk factors on the prognosis of patients with hepatocellular carcinoma (P<0.05). " 04/10/2017 - "Results: Expressions of hsa-mir-1180, hsa-mir-149, hsa-mir-744 and hsa-mir-940 were all up regulated in high invasion capable cell lines (SNU423, SNU449) and vascular invasion patients with hepatocellular carcinoma (logFC>1, P<0.05). " 04/10/2017 - "Conclusion: With TCGA and GEO data mining, we found that hsa-mir-1180, hsa-mir-149, hsa-mir-744 and hsa-mir-940 were all highly related to the prognosis of hepatocellular carcinoma, that enabled it to be used to further study the biomarkers related to the prognosis of hepatocellular carcinoma. "
2.	Neoplasms (Cancer) 01/01/2018 - "Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A." 11/19/2014 - "A novel miRNA, hsa-miR-940 (miR-940), identified and validated to be highly expressed in immortalized normal cells compared to cancer cells, is a regulator of MIEN1. " 01/01/2018 - "One of these miRNAs, hsa-miR-940, significantly promoted the osteogenic differentiation of human mesenchymal stem cells in vitro by targeting ARHGAP1 and FAM134A Interestingly, although MDA-MB-231 breast cancer cells are commonly known as an osteolytic phenotype-inducing cancer cell line, the implantation of miR-940-overexpressing MDA-MB-231 cells induced extensive osteoblastic lesions in the resulting tumors by facilitating the osteogenic differentiation of host mesenchymal cells. " 07/01/2017 - "Target genes (e.g., cyclin-dependent kinase 6) of hsa-miR-942-5p were mainly enriched in cancer-related pathways, whereas target genes (e.g., CRK-Like Proto-Oncogene, Adaptor Protein) of hsa-miR-940 were enriched in the ErbB signaling pathway. "
3.	Breast Neoplasms (Breast Cancer) 01/01/2018 - "One of these miRNAs, hsa-miR-940, significantly promoted the osteogenic differentiation of human mesenchymal stem cells in vitro by targeting ARHGAP1 and FAM134A Interestingly, although MDA-MB-231 breast cancer cells are commonly known as an osteolytic phenotype-inducing cancer cell line, the implantation of miR-940-overexpressing MDA-MB-231 cells induced extensive osteoblastic lesions in the resulting tumors by facilitating the osteogenic differentiation of host mesenchymal cells. " 06/04/2022 - "Analysis of online data also suggested that HIF-1-related transcription factors could suppress ZNF582-AS1 expression, and the lncRNA might bind to hsa-miR-940, a known oncogenic miRNA in breast cancer. "
4.	Sarcoma (Soft Tissue Sarcoma) 01/01/2021 - "Afterward, we constructed an immune infiltration-related risk score model based on the expression of IRF1, MFNG, hsa-miR-940, and hsa-miR-378a-5p, presenting a promising performance in predicting the prognosis of patients with sarcoma."
5.	Hypertension (High Blood Pressure) 10/25/2022 - "qRT-PCR test found that the expression of hsa-miR-100-5p, hsa-miR-299-5p, hsa-miR-299-3p, hsa-miR-196b-5p, hsa-miR-503-5p, hsa-miR-628-5p and hsa-miR-543 was up-regulated, while the expression of hsa-miR-150-5p, hsa-miR-296-5p, hsa-miR-874-3p and hsa-miR-940 was down-regulated in the hypertension group compared with the control group. " 10/25/2022 - "A total of 11 miRNAs related to hypertension were screened by GSEA enrichment analysis, including hsa-miR-100-5p, hsa-miR-150-5p, hsa-miR-299-5p, hsa-miR-299-3p, hsa-miR-296-5p, hsa-miR-196b-5p, hsa-miR-503-5p, hsa-miR-628-5p, hsa-miR-874-3p, hsa-miR-543 and hsa-miR-940. "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)
2.	human MIRN744 microRNA
3.	human MIRN149 microRNA
4.	human MIRN1180 microRNA
5.	MicroRNAs (MicroRNA)
6.	Long Noncoding RNA
7.	Cyclin-Dependent Kinase 6
8.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
9.	Transcription Factors (Transcription Factor)
10.	Proteins (Proteins, Gene)